Cat.No.L1600
A unique collection of 1015 Fragment compounds for Fragment-Based Drug Discovery (FBDD).
Cited by 3 Publications
| Range | Average | |
| MolWeight | 92 to 291 | 164.8 |
| LogP | <3.8 | 1.5 |
| Num_H_Acceptors | 0 to 6 | 2.4 |
| Num_H_Donors | 0 to 3 | 1 |
| Num_RotatableBonds | 0 to 8 | 1.5 |
| PSA | 0 to 99 | 8 |
| Formulation | 1015 compounds pre-dissolved in 10mM DMSO | ||
|---|---|---|---|
| Container | 96 Deep Well Plate Sealed With Aluminium Foil | ||
| Stability | 12 months | -20°C | in DMSO |
| 24 months | -80°C | in DMSO | |
| Shipping | Blue ice or dry ice | ||
Application of GPCR Compound Library in liver cancer (This article was published in Nature (IF
Application of Kinase Inhibitor Library in colorectal cancer (This article was published in Nature Communications (IF
Application of FDA-approved Drug Library in antivirus (This article was published in Cell Research (IF
Application of FDA-approved Drug Library in metabolism (This article was published in Movement Disorders (IF
Application of Epigenetics Compound Library in acute lymphoblastic leukaemia (This article was published in Blood (IF
Application of Inhibitor Library in tumour immunology (This article was published in Cancer Immunol Res (IF